Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis

References

• Keegan TH, Ries LA, Barr RD, et al. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer. 2016;122(7):1009–1016.
   PubMed Web of Science ®Google Scholar
• Muffly L, Alvarez E, Lichtensztajn D, et al. Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study. Blood Adv. 2018;2(8):895–903.
   PubMed Web of Science ®Google Scholar
• Albritton KH, Wiggins CH, Nelson HE, et al. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol. 2007;25(29):4616–4621.
   PubMed Web of Science ®Google Scholar
• Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of children’s cancer group and cancer and leukemia group B studies. Blood. 2008;112(5):1646–1654.
   PubMed Web of Science ®Google Scholar
• Alvarez EM, Malogolowkin M, Li Q, et al. Decreased early mortality in young adult patients with acute lymphoblastic leukemia treated at specialized cancer centers in California. J Oncol Pract. 2019;15(4):e316–e327.
   PubMed Web of Science ®Google Scholar
• Alvarez EM, Malogolowkin M, Hoch JS, et al. Treatment complications and survival among children and young adults with acute lymphoblastic leukemia. JCO Oncol Pract. 2020;16(10):e1120–e1133.
   PubMedGoogle Scholar
• Wolfson J, Sun CL, Wyatt L, et al. Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: impact of care at specialized cancer centers on survival outcome. Cancer Epidemiol Biomarkers Prev. 2017;26(3):312–320.
   PubMed Web of Science ®Google Scholar
• Denton CC, Rawlins YA, Oberley MJ, et al. Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. Pediatr Blood Cancer. 2018;65(3):e26891.
   Web of Science ®Google Scholar
• Hough R, Vora A. Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). Hematology Am Soc Hematol Educ Program. 2017;2017(1):251–258.
   PubMedGoogle Scholar
• Gupta AA, Chi YY, Anderson JR, et al. Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2017;64(9):e26479.
   Web of Science ®Google Scholar
• Zawitkowska J, Lejman M, Zaucha-Prazmo A, et al. Grade 3 and 4 toxicity profiles during therapy of childhood acute lymphoblastic leukemia. In Vivo. 2019;33(4):1333–1339.
   PubMed Web of Science ®Google Scholar
• Yost K, Perkins C, Cohen R, et al. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–711.
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
   PubMed Web of Science ®Google Scholar
• Meeske KA, Ji L, Freyer DR, et al. Comparative toxicity by sex among children treated for acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62(12):2140–2149.
   PubMed Web of Science ®Google Scholar
• Morse RB, Hall M, Fieldston ES, et al. Children’s hospitals with shorter lengths of stay do not have higher readmission rates. J Pediatr. 2013;163(4):1034–1038.e1.
   PubMed Web of Science ®Google Scholar
• Alvarez E, Keegan T, Johnston EE, et al. Adolescent and young adult oncology patients: disparities in access to specialized cancer centers. Cancer. 2017;123(13):2516–2523.
   PubMed Web of Science ®Google Scholar
• Schmiegelow K, Muller K, Mogensen SS, et al. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. F1000Res. 2017;6:444.
   PubMedGoogle Scholar
• Wedekind MF, Dennis R, Sturm M, et al. The effects of hospital length of stay on readmissions for children with newly diagnosed acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2016;38(5):329–333.
   PubMed Web of Science ®Google Scholar
• Villanueva MA, August KJ. Early discharge of neutropenic pediatric oncology patients admitted with fever. Pediatr Blood Cancer. 2016;63(10):1829–1833.
   PubMed Web of Science ®Google Scholar
• Bakk I, Koch T, Stanek J, et al. Steroid-induced hypertension during induction chemotherapy for acute lymphoblastic leukemia in US Children's Hospitals. J Pediatr Hematol Oncol. 2018;40(1):27–30.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Pihoker C, Hunt K, et al. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer. 2007;110(10):2313–2320.
   PubMed Web of Science ®Google Scholar
• Markham J, Hall M, Gay J, et al. Length of stay and cost of pediatric readmissions. Pediatrics. 2018;141(4):e20172934.
   PubMed Web of Science ®Google Scholar
• Kaul S, Korgenski EK, Ying J, et al. A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia. Cancer Med. 2016;5(2):221–229.
   PubMed Web of Science ®Google Scholar
• McNeer JL, Bleyer A. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults. Pediatr Blood Cancer. 2018;65(6):e26989.
   PubMed Web of Science ®Google Scholar
• Ho G, Jonas BA, Li Q, et al. Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia. Br J Haematol. 2017;177(5):791–799.
   PubMed Web of Science ®Google Scholar
• Lund B, Asberg A, Heyman M, et al. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2011;56(4):551–559.
   PubMed Web of Science ®Google Scholar
• Prucker C, Attarbaschi A, Peters C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster Study Group. Leukemia. 2009;23(7):1264–1269.
   PubMed Web of Science ®Google Scholar
• Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111(9):4477–4489.
   PubMed Web of Science ®Google Scholar